GHRYVELIN

This brand name is authorized in Austria, Estonia, France, Croatia, Ireland, Italy, Lithuania

Active ingredients

The drug GHRYVELIN contains one active pharmaceutical ingredient (API):

1 Macimorelin UNII AQZ1003RMG - MACIMORELIN ACETATE

Macimorelin is an orally available peptidomimetic with growth hormone (GH) secretagogue activity similar to ghrelin. Macimorelin stimulates GH release by activating growth hormone secretagogue receptors (GHSR) present in the pituitary and hypothalamus. Read about Macimorelin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GHRYVELIN Granules for oral suspension	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V04CD06		V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CD Tests for pituitary function
Discover more medicines within V04CD06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1787430
Country: FR	Base de données publique des médicaments	Identifier(s): 68930729
Country: IT	Agenzia del Farmaco	Identifier(s): 047527015
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086924